Search

everythinglearnresearchcommunity

for

Search:↓

Adding finasteride to minoxidil solution for hair loss treatment didn't show extra benefits, just increased cost and fear of side effects.

Hair loss drugs may cause sexual issues and infertility in men.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Some men taking finasteride for hair loss experienced anxiety, depression, and sexual problems, which sometimes continued after stopping the medication.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Post-finasteride syndrome's existence is uncertain; more research needed.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Topical dutasteride shows promise for hair loss but needs more research.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Consider benefits and risks of new alopecia treatments for safety.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Some nonsurgical hair loss treatments are effective, especially if started early.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.